The overall objective of this program project is to understand how macrophages become activated/deactivated for tumor cell killing. The group's efforts will be led by an established scientist in the field, who is also an experienced biomedical administrator, Dr. Stephen W. Russell. The objective of the first project leader, Dr. David C. Morrison, is to establish how LPS initiates activation. He will focus on the receptor proteins for LPS that he has discovered, as well as hydrophobic interactions between LPS and macrophage membranes that may contribute to initiation of the signal(s) for activation. Dr. Tsuneo Suzuki (project leader #2) will investigate the hypothesis that LPS binding to macrophages activates protein kinase C (PKC) by triggering phosphatidylinositol turnover as well as activation of the neutral intracellular proteinase, calpain, which then cleaves and activates PKC. Dr. Russell (project leader #3) will have as his group's goal the delineation of precisely how type I interferons affect activation. His emphasis will primarily be on how the induction and expression of cytolytic mechanisms are affected, as well as positive and negative autocrine/paracrine regulatory effects of macrophage- produced IFN. The associated regulatory mechanisms will be defined. Dr. Michael J. Parmely (project leader #4) and his group will focus on the role that TGF-beta has in regulating the activation of mouse macrophages. Specifically, he will characterize the production of latent and active forms of TGF-beta by mouse macrophages, determine how active TGF-beta affects the mediation of tumoricidal activity by activated macrophages, and ascertain the extent to which these regulatory effects are of autocrine origin. The Core Component, consisting of administrative support under the supervision of Dr. Russell, will be the means by which maximal integration and, therefore, synergism among the various projects is obtained. The Core Component's Research Program Coordinator will provide administrative support that is designed to make the projects function as integral parts of a whole, rather than as independent endeavors. Because of the natural complementarity of the projects and the essential, central functions that will be provided by the Core Component, it is hard to imagine how the group interactions and synergism that are sought as general goals of any program project will not be realized here.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA054474-03
Application #
2095969
Study Section
Special Emphasis Panel (SRC (J2))
Project Start
1992-02-01
Project End
1995-01-31
Budget Start
1994-02-01
Budget End
1995-01-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Kansas
Department
Pathology
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Zhang, Yue H; Murphy, William J; Russell, Stephen W et al. (2005) Serum-dependent potentiation of lipopolysaccharide-induced nitric oxide production is mediated by the events after the transcription of inducible type of nitric oxide synthase. Cell Immunol 234:16-22
Crespo, A; Filla, M B; Russell, S W et al. (2000) Indirect induction of suppressor of cytokine signalling-1 in macrophages stimulated with bacterial lipopolysaccharide: partial role of autocrine/paracrine interferon-alpha/beta. Biochem J 349:99-104
Gao, J J; Filla, M B; Lorsbach, R B et al. (2000) Prolonged exposure of mouse macrophages to IFN-beta suppresses transcription of the inducible nitric oxide synthase gene: altered availability of transcription factor Stat1alpha. Eur J Immunol 30:1551-61
Xia, D; Wang, F; Parmely, M J (2000) Inhibition of nuclear factor-kappab activation in mouse macrophages and the RAW 264.7 cell line by a synthetic adenyl carbocyclic nucleoside. Biochem Pharmacol 60:717-27
David, S A; Awasthi, S K; Balaram, P (2000) The role of polar and facial amphipathic character in determining lipopolysaccharide-binding properties in synthetic cationic peptides. J Endotoxin Res 6:249-56
David, S A; Silverstein, R; Amura, C R et al. (1999) Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother 43:912-9
Morrison, D C; Silverstein, R; Luchi, M et al. (1999) Structure-function relationships of bacterial endotoxins. Contribution to microbial sepsis. Infect Dis Clin North Am 13:313-40
Gao, J J; Zuvanich, E G; Xue, Q et al. (1999) Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages. J Immunol 163:4095-9
Kielian, T; Nagai, E; Ikubo, A et al. (1999) Granulocyte/macrophage-colony-stimulating factor released by adenovirally transduced CT26 cells leads to the local expression of macrophage inflammatory protein 1alpha and accumulation of dendritic cells at vaccination sites in vivo. Cancer Immunol Immunother 48:123-31
Ito, N; Li, Y; Suzuki, T et al. (1998) Transient degradation of NF-kappaB proteins in macrophages after interaction with mast cell granules. Mediators Inflamm 7:397-407

Showing the most recent 10 out of 58 publications